StockDuty ← Dashboard Sep 04, 2026 12:05 AM ET
SignalFDA/Bio

PANCREATIC CANCER DRUG MAY HOLD PROMISE FOR LUNG CANCER AS WELL, EARLY STUDY SUGGESTS - ABC

Early study suggests drug efficacy expands from pancreatic to lung cancer.

Early study suggests drug efficacy expands from pancreatic to lung cancer.
Early study suggests drug efficacy expands from pancreatic to lung cancer. — impact context not separately stored; see What changed.
Sources